140 related articles for article (PubMed ID: 24218432)
1. Long-term antihypertensive treatment fails to improve E/e' despite regression of left ventricular mass: an Anglo-Scandinavian cardiac outcomes trial substudy.
Barron AJ; Hughes AD; Sharp A; Baksi AJ; Surendran P; Jabbour RJ; Stanton A; Poulter N; Fitzgerald D; Sever P; O'Brien E; Thom S; Mayet J;
Hypertension; 2014 Feb; 63(2):252-8. PubMed ID: 24218432
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J;
Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of antihypertensive treatment on left ventricular diastolic function: an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
Tapp RJ; Sharp A; Stanton AV; O'Brien E; Chaturvedi N; Poulter NR; Sever PS; Thom SA; Hughes AD; Mayet J;
J Am Coll Cardiol; 2010 Apr; 55(17):1875-81. PubMed ID: 20413040
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
[TBL] [Abstract][Full Text] [Related]
5. ASCOT - blood pressure arm confirms efficacy of amlodipine/perindopril (Norvasc)/Coversyl) regimen.
Cardiovasc J S Afr; 2005; 16(5):271-2; discussion 272, 274-5. PubMed ID: 16307160
[No Abstract] [Full Text] [Related]
6. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
[TBL] [Abstract][Full Text] [Related]
7. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial.
Spencer CG; Felmeden DC; Blann AD; Lip GY
Am J Hypertens; 2007 Jun; 20(6):699-704. PubMed ID: 17531931
[TBL] [Abstract][Full Text] [Related]
8. Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy.
Müller-Brunotte R; Edner M; Malmqvist K; Kahan T
J Hypertens; 2005 Mar; 23(3):633-40. PubMed ID: 15716707
[TBL] [Abstract][Full Text] [Related]
9. Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Müller-Brunotte R; Kahan T; Malmqvist K; Ring M; Edner M
Am J Hypertens; 2006 Sep; 19(9):927-36. PubMed ID: 16942935
[TBL] [Abstract][Full Text] [Related]
10. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
de Luca N; Asmar RG; London GM; O'Rourke MF; Safar ME;
J Hypertens; 2004 Aug; 22(8):1623-30. PubMed ID: 15257187
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of antihypertensive treatment on the retinal microcirculation: an anglo-scandinavian cardiac outcomes trial substudy.
Thom S; Stettler C; Stanton A; Witt N; Tapp R; Chaturvedi N; Allemann S; Mayet J; Sever P; Poulter N; O'Brien E; Hughes A
Hypertension; 2009 Aug; 54(2):405-8. PubMed ID: 19528363
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of cardiovascular events by the antihypertensive treatment using amlodipine and perindopril in comparison with the use of atenolol and bendroflumethiazide. The ASCOT (Anglo-Scandinavian Outcomes Trail: blood pressure lowering arm) study results--multicentre, randomised, controlled trial. Landmark in the development of opinions on combination therapy in hypertension? (comment)].
Widimský J
Vnitr Lek; 2005 Dec; 51(12):1394-6, 1398-9. PubMed ID: 16430107
[TBL] [Abstract][Full Text] [Related]
13. Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Poulter NR; Dobson JE; Sever PS; Dahlöf B; Wedel H; Campbell NR;
J Am Coll Cardiol; 2009 Sep; 54(13):1154-61. PubMed ID: 19761936
[TBL] [Abstract][Full Text] [Related]
14. Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: an Anglo-Scandinavian Cardiac Outcome Trial substudy.
Manisty CH; Zambanini A; Parker KH; Davies JE; Francis DP; Mayet J; McG Thom SA; Hughes AD;
Hypertension; 2009 Oct; 54(4):724-30. PubMed ID: 19704107
[TBL] [Abstract][Full Text] [Related]
15. Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy.
Sharp A; Tapp R; Francis DP; McG Thom SA; Hughes AD; Stanton AV; Zambanini A; Chaturvedi N; Byrd S; Poulter NR; Sever PS; Mayet J
J Am Coll Cardiol; 2008 Sep; 52(12):1015-21. PubMed ID: 18786484
[TBL] [Abstract][Full Text] [Related]
16. Azelnidipine plus olmesartan versus amlodipine plus olmesartan on arterial stiffness and cardiac function in hypertensive patients: a randomized trial.
Takami T; Saito Y
Drug Des Devel Ther; 2013; 7():175-83. PubMed ID: 23662047
[TBL] [Abstract][Full Text] [Related]
17. Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial).
Radchenko GD; Mushtenko LO; Sirenko YM
Vasc Health Risk Manag; 2018; 14():265-278. PubMed ID: 30349279
[TBL] [Abstract][Full Text] [Related]
18. Low-dose quadruple antihypertensive combination: more efficacious than individual agents--a preliminary report.
Mahmud A; Feely J
Hypertension; 2007 Feb; 49(2):272-5. PubMed ID: 17178976
[TBL] [Abstract][Full Text] [Related]
19. The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Ostergren J; Poulter NR; Sever PS; Dahlöf B; Wedel H; Beevers G; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E;
J Hypertens; 2008 Nov; 26(11):2103-11. PubMed ID: 18854748
[TBL] [Abstract][Full Text] [Related]
20. The effects of antihypertensive treatment on the doppler-derived myocardial performance index in patients with hypertensive left ventricular hypertrophy: results from the Swedish irbesartan in left ventricular hypertrophy investigation versus atenolol (SILVHIA).
Liljedahl S; Kahan T; Lind L; Arnlöv J
Echocardiography; 2009 Aug; 26(7):753-8. PubMed ID: 19486119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
